NewsRoom Articles - Page 916 of 1454

TuesdayMar 19, 2019 1:30 pm

Renewable Energy Group Inc. (NASDAQ: REGI) Attends 31st Annual ROTH Conference

Renewable Energy Group (NASDAQ: REGI) is a provider of cleaner, lower carbon intensity products and services. The company is an international producer of biomass-based diesel, a developer of renewable chemicals and North America's largest producer of advanced biofuel. REG utilizes an integrated procurement, distribution, and logistics network to convert natural fats, oils, greases, and sugars into lower carbon intensity products. With 14 active biorefineries, a feedstock processing facility, research and development capabilities and a diverse and growing intellectual property portfolio, REG is committed to being a long-term leader in bio-based fuel and chemicals. For more information, visit the company's website…

TuesdayMar 19, 2019 1:30 pm

CymaBay Therapeutics Inc. (NASDAQ: CBAY) Attends 31st Annual ROTH Conference

CymaBay Therapeutics (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with nonalcoholic steatohepatitis (NASH). Two phase 2 studies of seladelpar established proof-of-concept in PBC. CymaBay is currently conducting a phase 3 study of seladelpar for PBC and a phase 2b study of seladelpar for NASH. For more information, visit the company's website at www.cymabay.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

TuesdayMar 19, 2019 1:30 pm

ReneSola Ltd. (NYSE: SOL) Attends 31st Annual ROTH Conference

ReneSola (NYSE: SOL) is a leading international manufacturer and supplier of green energy products. Leveraging its global presence with offices and warehouses in more than 16 countries and expansive production facilities and sales network, ReneSola is well-positioned to provide the highest quality green energy products and on-time services for EPC, installers and green energy projects around the world. ReneSola is focused on improving production efficiency and continually developing new product lines to provide additional value to its portfolio of green energy offerings. The company has expanded into energy storage solutions and energy efficient lighting, among other product categories. For more…

TuesdayMar 19, 2019 1:30 pm

Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) Attends 31st Annual ROTH Conference

Cyclacel Pharmaceuticals (NASDAQ: CYCC) is a clinical-stage biopharmaceutical company using its expertise in cell cycle, transcriptional regulation and DNA damage response biology in cancer cells to develop innovative medicines. The transcriptional regulation program is evaluating CYC065, a CDK inhibitor, in patients with advanced solid cancers and in combination with venetoclax in patients with advanced hematological malignancies. The DNA damage response program is evaluating a combination of sapacitabine and seliciclib, a CDK inhibitor, in BRCA positive patients with advanced solid cancers and sapacitabine and olaparib, a PARP inhibitor, in BRCA positive patients with breast cancer. For more information, visit the company's…

TuesdayMar 19, 2019 1:30 pm

Daqo New Energy Corp. (NYSE: DQ) Attends 31st Annual ROTH Conference

Daqo New Energy (NYSE: DQ) is a manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2008, the company is one of the world’s lowest cost producers of high-purity polysilicon. Daqo’s highly efficient and technically advanced manufacturing facility in Xinjiang, China, currently has an annual polysilicon production capacity of 30,000 metric tons, and the company is undergoing a debottlenecking project and a capacity expansion project and expects to increase its annual polysilicon production capacity to 70,000 metric tons in the first quarter of 2020. For more information, visit the company's website at www.dqsolar.com. About NetworkNewsWire NetworkNewsWire (NNW)…

TuesdayMar 19, 2019 1:30 pm

Cytori Therapeutics Inc. (NASDAQ: CYTX) Attends 31st Annual ROTH Conference

Cytori Therapeutics (NASDAQ: CYTX) is developing, manufacturing and commercializing nanoparticle-delivered oncology drugs and autologous adipose-derived regenerative cell (ADRC) therapies within its Nanomedicine and Cell Therapy franchises, respectively. Cytori Nanomedicine is focused on the liposomal encapsulation of anti-neoplastic chemotherapy agents, which may enable the effective delivery of the agents to target sites while reducing systemic toxicity. Cytori Cell Therapy, prepared within several hours with the proprietary Celution System and administered to the patient the same day, has been shown in preclinical and clinical studies to act principally by improving blood flow, modulating the immune system, and facilitating wound repair. For more…

TuesdayMar 19, 2019 1:30 pm

Cypress Semiconductor Corp. (NASDAQ: CY) Attends 31st Annual ROTH Conference

Cypress Semiconductor (NASDAQ: CY) provides advanced embedded solutions for the world’s most innovative automotive, industrial, smart home appliances, consumer electronics and medical products. Cypress’ microcontrollers, wireless and USB-based connectivity solutions, analog ICs, and reliable, high-performance memories help engineers design differentiated products and get them to market first. Cypress is committed to providing customers with the best support and development resources on the planet enabling them to disrupt markets by creating new product categories in record time. For more information, visit the company's website at www.cypress.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1)…

TuesdayMar 19, 2019 1:30 pm

Remark Holdings Inc. (NASDAQ: MARK) Attends 31st Annual ROTH Conference

Remark Holdings (NASDAQ: MARK) delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in a wide range of applications within the retail, financial, public safety and workplace arenas. The company also owns and operates digital media properties that deliver relevant, dynamic content and ecommerce solutions. The company is headquartered in Las Vegas, Nevada, with additional operations in Los Angeles, California and in Beijing, Shanghai, Chengdu and Hangzhou, China. For more information, visit the company's website at www.remarkholdings.com. About NetworkNewsWire…

TuesdayMar 19, 2019 1:30 pm

Reed’s Inc. (NYSE American: REED) Attends 31st Annual ROTH Conference

Reed's (NYSE American: REED) has sold over 500 million bottles of its category leading natural, handcrafted beverages. Reed’s is America’s No. 1 selling Ginger Beer brand. Virgil’s is America’s No. 1 selling independent, full line of natural craft sodas. The Reed’s Inc. portfolio is sold in over 30,000 retail locations across the natural, specialty, grocery, drug, club and mass channels nationwide. Reed’s Ginger Beers are unique to the category because of the proprietary process of hand brewing its award-winning products. The company uses the same handcrafted approach and dedication to the highest quality ingredients in its award-winning Virgil’s line of…

TuesdayMar 19, 2019 1:30 pm

RedHill Biopharma Ltd. (NASDAQ: RDHL) Attends 31st Annual ROTH Conference

RedHill Biopharma (NASDAQ: RDHL) is a specialty biopharmaceutical company, primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases and cancer. RedHill’s pipeline includes several drug candidates in advanced clinical development stages addressing clear medical needs and aiming to relieve suffering and save lives. RedHill’s drugs are largely de-risked and are potentially of lower cost and faster to market than new chemical entities under development. RedHill’s products are based on several technology platforms and address several disease targets, thus providing for risk diversification. For more information, visit the company's website at www.redhillbio.com.…